| Product Code: ETC9561297 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Sweden continued to rely on imports of oral hypoglycemic agents (OHAs) from neighboring countries such as Denmark, Belgium, Germany, Netherlands, and Italy. Despite the diverse sourcing, the market remained competitive with a low Herfindahl-Hirschman Index (HHI) concentration. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 4.69%, indicating a stable market. Notably, the growth rate spiked in 2024 by 17.54%, suggesting a potential shift or increased demand within the Swedish OHA market. Overall, the import landscape for OHAs in Sweden presents opportunities for further market expansion and competition.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2022 & 2032F |
3.3 Sweden Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Sweden Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2022 & 2032F |
3.6 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2022 & 2032F |
4 Sweden Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Sweden |
4.2.2 Growing awareness and focus on diabetes management |
4.2.3 Technological advancements in oral hypoglycemic agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High competition among key market players |
4.3.3 Potential side effects and safety concerns associated with oral hypoglycemic agents |
5 Sweden Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Sweden Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Sweden Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2022 - 2032F |
6.1.3 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2022 - 2032F |
6.1.4 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.1.5 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2022 - 2032F |
6.1.6 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2022 - 2032F |
6.2 Sweden Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2022 - 2032F |
6.2.3 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2022 - 2032F |
7 Sweden Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Sweden Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Sweden Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Patient adherence rate to oral hypoglycemic agents |
8.2 Prescription rates by healthcare providers |
8.3 Number of clinical trials and research studies on oral hypoglycemic agents |
8.4 Patient satisfaction and feedback on the effectiveness of oral hypoglycemic agents |
8.5 Adoption rate of new oral hypoglycemic agents in the market. |
9 Sweden Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Sweden Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2022 & 2032F |
9.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2022 & 2032F |
10 Sweden Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Sweden Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2025 |
10.2 Sweden Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here